Becton Dickinson Japan Enters Cervical Cytology Screening Business
This article was originally published in PharmAsia News
Executive Summary
Becton Dickinson Japan has started cervical cytology screening with the company's launch of the BD FocalPoint system in July. BD Japan also plans to market SurePath Pap test and PrepStain Slide Processor starting in January, when a license expires with Medical and Biologic Laboratories. MBL is currently marketing the two products in Japan. With a business focus on cervical cytology screening, BD Japan is strengthening marketing operations and plans to enter the prevention medical market. (Click here for more - Japanese language)